-

HLTH and Evercore ISI Partner for 2nd Year to Host Innovative Therapeutic Leaders

Evercore to host program featuring leading industry executives at HLTH VRTL on October 16, 2020

NEW YORK--(BUSINESS WIRE)--HLTH, the leading platform bringing together the health ecosystem, and Evercore (NYSE: EVR) announced today they will collaborate for the second consecutive year to host a dedicated program on Digital Therapeutics at HLTH VRTL 2020, taking place virtually October 12-16th.

The program, titled “Digging into Digital Therapeutics: A New Dimension in Treatment,” will be held on October 16 from 11am-2:30pm. It will include five panels with leading industry executives who will cover topics including clinical adoption, pharma partnerships, working with payors and the impact COVID-19 has had on accelerating regulatory development and access to digital therapies.

“Digital Therapeutics brings a new dimension to patient care within an industry that has undergone significant transformation over the past year. 2020 has brought not only COVID-induced changes to the practice of medicine, but also FDA approvals, and greater provider and patient interest in these innovative treatments,” said Elizabeth Anderson, Evercore ISI’s Healthcare Technology & Distribution analyst. “We are thrilled to partner again with HLTH and for the opportunity to share updates from this quickly-evolving sector with a wider audience.”

“We’re excited for the opportunity to partner with Evercore ISI again for HLTH VRTL this year. Now more than ever, this is a unique opportunity to learn how industry leaders are bringing their expertise and community of innovators to the discussion on creating health’s future,” said Jonathan Weiner, Founder, Chairman, and CEO of HLTH.

For more information, please visit https://www.hlth.com/virtual/partners/specialty-content/evercore-isi

About Evercore

Evercore (NYSE: EVR) is a premier global independent investment banking advisory firm. We are dedicated to helping our clients achieve superior results through trusted independent and innovative advice on matters of strategic significance to boards of directors, management teams and shareholders, including mergers and acquisitions, strategic shareholder advisory, restructurings, and capital structure. Evercore also assists clients in raising public and private capital and delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors. Founded in 1995, the Firm is headquartered in New York and maintains offices and affiliate offices in major financial centers in the Americas, Europe, the Middle East and Asia. For more information, please visit www.evercore.com.

About HLTH

HLTH (pronounced “health”) is the leading platform bringing together the entire health ecosystem, focused on health innovation and transformation. From unparalleled events with industry-leading speakers to inspirational digital content and mission-driven initiatives, HLTH creates a unique marketplace for the health community leading the dialogue and development of a new health ecosystem.

Contacts

Evercore Business Contact:
Elizabeth Anderson
+1.212.446.5632

HLTH Contact
Carolyn Joyce
+1.347.857.3100

Media Contact:
Dana Gorman
Abernathy MacGregor, for Evercore
+1.212.371.5999

Evercore

NYSE:EVR

Release Versions

Contacts

Evercore Business Contact:
Elizabeth Anderson
+1.212.446.5632

HLTH Contact
Carolyn Joyce
+1.347.857.3100

Media Contact:
Dana Gorman
Abernathy MacGregor, for Evercore
+1.212.371.5999

More News From Evercore

Evercore ISI Ranked No. 1 on Weighted Basis in 2026 Extel All-America Research Analyst Survey

NEW YORK--(BUSINESS WIRE)--Evercore ISI ranked No. 1 among all firms on a weighted basis in the analyst rankings of the 2026 Extel (previously Institutional Investor) All-America Research Team survey, marking its fifth consecutive year in the top position. The weighted ranking assigns greater value to higher placements, with first-place rankings contributing more than second- and third-place rankings. Evercore research analysts were recognized as Top 3 or Runner-Up in 40 categories. The firm ea...

John Vaske Joins Evercore as Senior Managing Director in the Chemicals Investment Banking Group

NEW YORK--(BUSINESS WIRE)--Evercore announced today that John Vaske has joined the firm as a senior managing director in its chemicals investment banking group. He will be based in New York. Naveen Nataraj, co-head of U.S. Investment Banking, said, “John brings a unique perspective shaped by his experience as both a trusted advisor and senior corporate executive. His deep knowledge of the chemicals sector, extensive transaction experience and longstanding industry relationships will be highly v...

Evercore Appoints Nigel Dawn and Naveen Nataraj as Co-Presidents

NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) today announced that its Board of Directors has appointed Nigel Dawn and Naveen Nataraj as Co-Presidents of the firm, effective January 1, 2027. Mr. Dawn and Mr. Nataraj will report to Chairman and Chief Executive Officer John S. Weinberg, who will continue to lead Evercore, its Management Committee and the firm’s strategic direction. Evercore’s Board and Mr. Weinberg have agreed that he will serve as Chairman and CEO for at least the next three y...
Back to Newsroom